Ealixir (OTCMKTS:EAXR) (OTCMKTS:EAXR) is a developer and marketer of liquid nutritional supplements designed to support overall health and wellness. The company formulates a range of products that include vitamin elixirs, botanical extracts, detox solutions and sports nutrition blends. Ealixir’s offering emphasizes natural ingredients sourced from certified growers, and its proprietary manufacturing process ensures high bioavailability and consistent quality for each batch.
Founded in 2016 and headquartered in Miami, Florida, Ealixir operates a fully owned production facility in Guadalajara, Mexico and maintains research partnerships with labs in the United States. The company’s global supply chain spans North America and Latin America, with distribution channels that include e-commerce platforms, specialty health food stores and strategic retail partnerships. Ealixir has garnered attention for its targeted formulations that address hormonal balance, immune support, and digestive health.
Central to Ealixir’s strategy is its in-house research and development team, led by CEO Dr. John H. Hawthorne, a nutritional biochemist with over 20 years of experience in dietary supplement innovation. Under Dr. Hawthorne’s guidance, the company has secured regulatory approvals for several key products and is exploring novel delivery systems such as nanoemulsion and liposomal encapsulation to enhance nutrient absorption.
As it continues to expand its footprint, Ealixir is focused on building brand awareness through educational campaigns and medical practitioner endorsements. The company is actively pursuing growth opportunities across emerging markets in Latin America and Asia, while further strengthening its direct-to-consumer sales model in the United States. With a commitment to rigorous quality standards and sustainable sourcing, Ealixir aims to establish itself as a leading name in liquid nutritional supplementation.
